» Articles » PMID: 25572397

Mechanisms Mediating Enhanced Neutralization Efficacy of Staphylococcal Enterotoxin B by Combinations of Monoclonal Antibodies

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2015 Jan 10
PMID 25572397
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Staphylococcal enterotoxin B (SEB) is a superantigen that cross-links the major histocompatibility complex class II and specific V-β chains of the T-cell receptor, thus forming a ternary complex. Developing neutralizing mAb to disrupt the ternary complex and abrogate the resulting toxicity is a major therapeutic challenge because SEB is effective at very low concentrations. We show that combining two SEB-specific mAbs enhances their efficacy, even though one of the two mAbs by itself has no effect on neutralization. Crystallography was employed for fine-mapping conformational epitopes in binary and ternary complexes between SEB and Fab fragments. NMR spectroscopy was used to validate and identify subtle allosteric changes induced by mAbs binding to SEB. The mapping of epitopes established that a combination of different mAbs can enhance efficacy of mAb-mediated protection from SEB induced lethal shock by two different mechanisms: one mAb mixture promoted clearance of the toxin both in vitro and in vivo by FcR-mediated cross-linking and clearance, whereas the other mAb mixture induced subtle allosteric conformational changes in SEB that perturbed formation of the SEB·T-cell receptor·major histocompatibility complex class II trimer. Finally structural information accurately predicted mAb binding to other superantigens that share conformational epitopes with SEB. Fine mapping of conformational epitopes is a powerful tool to establish the mechanism and optimize the action of synergistic mAb combinations.

Citing Articles

Direct Mapping of Polyclonal Epitopes in Serum by HDX-MS.

Vorauer C, Boniche-Alfaro C, Murphree T, Matsui T, Weiss T, Fries B Anal Chem. 2024; 96(42):16758-16767.

PMID: 39434663 PMC: 11583827. DOI: 10.1021/acs.analchem.4c03274.


A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B.

Fan H, Zhao L, Wang W, Yu F, Jing H, Yang Y Hum Vaccin Immunother. 2024; 20(1):2360338.

PMID: 38857905 PMC: 11182437. DOI: 10.1080/21645515.2024.2360338.


Interaction Between SARS-CoV-2 and Pathogenic Bacteria.

Fazel P, Sedighian H, Behzadi E, Kachuei R, Fooladi A Curr Microbiol. 2023; 80(7):223.

PMID: 37222840 PMC: 10206355. DOI: 10.1007/s00284-023-03315-y.


Dietary supplementation with spray-dried animal plasma improves vaccine protection in aged mice.

Miro L, Rosell-Cardona C, Amat C, Polo J, Moreto M, Perez-Bosque A Front Nutr. 2023; 10:1050961.

PMID: 37032769 PMC: 10080719. DOI: 10.3389/fnut.2023.1050961.


SARS-CoV-2 Spike Does Not Possess Intrinsic Superantigen-like Inflammatory Activity.

Amormino C, Tedeschi V, Paldino G, Arcieri S, Fiorillo M, Paiardini A Cells. 2022; 11(16).

PMID: 36010602 PMC: 9406418. DOI: 10.3390/cells11162526.


References
1.
Hamad A, Herman A, Marrack P, Kappler J . Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B. J Exp Med. 1994; 180(2):615-21. PMC: 2191591. DOI: 10.1084/jem.180.2.615. View

2.
Papageorgiou A, Tranter H, Acharya K . Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J Mol Biol. 1998; 277(1):61-79. DOI: 10.1006/jmbi.1997.1577. View

3.
Davies J, Gordon S . Isolation and culture of murine macrophages. Methods Mol Biol. 2004; 290:91-103. DOI: 10.1385/1-59259-838-2:091. View

4.
Pettitt J, Zeitlin L, Kim D, Working C, Johnson J, Bohorov O . Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci Transl Med. 2013; 5(199):199ra113. DOI: 10.1126/scitranslmed.3006608. View

5.
OHara J, Mantis N . Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro. J Immunol Methods. 2013; 395(1-2):71-8. PMC: 3753220. DOI: 10.1016/j.jim.2013.06.004. View